The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
Open accessAbstract
INTRODUCTION: The COVID-19 pandemic has created a public health crisis, infected millions of people, and caused a significant number of deaths. SARS-CoV-2 transmits from person to person through several routes, mainly via respiratory droplets, which makes it difficult to contain its spread into the community. Here, we provide an overview of the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of COVID-19. AREAS COVERED: Direct person-to-person respiratory transmission has rapidly amplified the spread of coronavirus. In the absence of any clinically proven treatment options, the current clinical management of COVID-19 includes symptom management, infection prevention and control measures, optimized supportive care, and intensive care support in severe or critical illness. Developing an effective vaccine is now a leading research priority. Some vaccines have already been approved by the regulatory authorities for the prevention of COVID-19. EXPERT OPINION: General prevention and protection measures regarding the containment and management of the second or third waves are necessary to minimize the risk of infection. Until now, four vaccines reported variable efficacies of between 62-95%, and two of them (Pfizer/BioNTech and Moderna) received FDA emergency use authorization. Equitable access and effective distribution of these vaccines in all countries will save millions of lives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · cited 1×
“and coronary heart disease (6–8%) [104,111].”
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475 · cited 1×
“that dexamethasone reduced mortality by one-third in critically ill COVID-19 patients [184,185].”
BackgroundYang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897 · cited 1×
“A study showed that the S protein of SARSCoV-2 is 10 to 20 times more likely to bind to human ACE2 than the S protein of the early 2000s SARS-CoV strain [55].”
BackgroundStructure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2180-5 · Cited by 5,983
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · cited 1×
“It is worth noting that the ACE2 protein is also expressed by enterocytes in the small intestine [67].”
BackgroundA Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D. A. M. P. J., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.013 · Cited by 5,028 · cited 2×
“admitted to the ICU should receive pharmacological thrombosis prophylaxis [222].”
BackgroundDetection of SARS-CoV-2 in Different Types of Clinical Specimens
Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., & Tan, W. (2020) · JAMA · doi:10.1001/jama.2020.3786 · Cited by 5,028
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M., Liang, L., Huang, H., Hong, Z., Yu, J., Kang, M., Song, Y., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,810
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735 · cited 3×
“the consumption of wild animals was the main route of SARSCoV-2 transmission [5].”
BackgroundKorber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Temporal dynamics in viral shedding and transmissibility of COVID-19
He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0869-5 · Cited by 4,247
A Review of Coronavirus Disease-2019 (COVID-19)
Singhal, T. (2020) · The Indian Journal of Pediatrics · doi:10.1007/s12098-020-03263-6 · Cited by 3,537
Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31022-9 · Cited by 3,440
The reproductive number of COVID-19 is higher compared to SARS coronavirus
Liu, Y., Gayle, A. A., Wilder-Smith, A., & Rocklöv, J. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa021 · Cited by 3,192
Cell entry mechanisms of SARS-CoV-2
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003138117 · Cited by 3,142
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,911
CDC Weekly, C., & The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · China CDC Weekly · doi:10.46234/ccdcw2020.032 · Cited by 2,889
CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis), Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clere-Jehl, R., Schenck, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,792
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
WHO Solidarity Trial Consortium (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2023184 · Cited by 2,745
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M. L., Lescure, F.-X., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007016 · Cited by 2,737
Wilder-Smith, A., & Freedman, D. O. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa020 · Cited by 2,727 · cited 2×
“Public health and preventive approaches are the current strategies to curb the transmission of COVID-19 and focus on testing, case tracing, isolation, social distancing, and personal hygiene [142].”
BackgroundEffective treatment of severe COVID-19 patients with tocilizumab
Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005615117 · Cited by 2,647
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Bonilla-Aldana, D. K., Franco-Paredes, C., Henao-Martinez, A. F., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101623 · Cited by 2,542 · cited 1×
“Such measures were also found to reduce infection, mortality, and intensive care unit (ICU) admissions [58,146,147].”
BackgroundFolegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419 · cited 1×
“encoding full-length S protein with a tissue plasminogen activator signal peptide [248].”
BackgroundGender Differences in Patients With COVID-19: Focus on Severity and Mortality
Jin, J.-M., Bai, P., He, W., Wu, F., Liu, X.-F., Han, D.-M., Liu, S., & Yang, J.-K. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00152 · Cited by 2,325
F. T. Z. H. O. W. U. N. C. M. A. R. T., Jin, Y.-H., Cai, L., Cheng, Z.-S., Cheng, H., Deng, T., Fan, Y.-P., Fang, C., Huang, D., Huang, L.-Q., et al. (2020) · Military Medical Research · doi:10.1186/s40779-020-0233-6 · Cited by 2,254
Ong, S. W. X., Tan, Y. K., Chia, P. Y., Lee, T. H., Ng, O. T., Wong, M. S. Y., & Marimuthu, K. (2020) · JAMA · doi:10.1001/jama.2020.3227 · Cited by 2,140
Coronavirus Infections—More Than Just the Common Cold
Paules, C. I., Marston, H. D., & Fauci, A. S. (2020) · JAMA · doi:10.1001/jama.2020.0757 · Cited by 2,136
Coronavirus disease (COVID-19) pandemic.
Rampal, L., & Liew, B. S. (2020) · PubMed · Cited by 2,123
The Architecture of SARS-CoV-2 Transcriptome
Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020) · Cell · doi:10.1016/j.cell.2020.04.011 · Cited by 2,123 · cited 2×
“structural base proteins: spike (S), envelope (E), membrane (M), and nucleocapsid (N) [32,33].”
BackgroundCoronavirus envelope protein: current knowledge
Schoeman, D., & Fielding, B. C. (2019) · Virology Journal · doi:10.1186/s12985-019-1182-0 · Cited by 2,074
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,031
Pan, A., Liu, L., Wang, C., Guo, H., Hao, X., Wang, Q., Huang, J., He, N., Yu, H., Lin, X., et al. (2020) · JAMA · doi:10.1001/jama.2020.6130 · Cited by 1,931 · cited 2×
“If SARS-CoV-2 is compared to influenza and other diseases, the high R0, which varies from to 3–5, is representative of a more contagious infection [22,23]”
BackgroundZhao, S., Lin, Q., Ran, J., Musa, S. S., Yang, G., Wang, W., Lou, Y., Gao, D., Yang, L., He, D., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.050 · Cited by 1,853
Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.022 · Cited by 1,852
Zhang, W., Du, R.-H., Li, B., Zheng, X.-S., Yang, X.-L., Hu, B., Wang, Y.-Y., Xiao, G.-F., Yan, B., Shi, Z.-L., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1729071 · Cited by 1,799
Potential Effects of Coronaviruses on the Cardiovascular System: A Review
Madjid, M., Safavi-Naeini, P., Solomon, S. D., & Vardeny, O. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1286 · Cited by 1,793
COVID-19 outbreak: Migration, effects on society, global environment and prevention
Chakraborty, I., & Maity, P. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138882 · Cited by 1,789
Diagnosing COVID-19: The Disease and Tools for Detection
Udugama, B., Kadhiresan, P., Kozlowski, H. N., Malekjahani, A., Osborne, M., Li, V. Y. C., Chen, H., Mubareka, S., Gubbay, J. B., & Chan, W. C. W. (2020) · ACS Nano · doi:10.1021/acsnano.0c02624 · Cited by 1,754
Viral dynamics in mild and severe cases of COVID-19
Liu, Y., Yan, L.-M., Wan, L., Xiang, T.-X., Le, A., Liu, J.-M., Peiris, M., Poon, L. L. M., & Zhang, W. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30232-2 · Cited by 1,727
Coutard, B., Valle, C., de Lamballerie, X., Canard, B., Seidah, N. G., & Decroly, E. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104742 · Cited by 1,679
Tai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0400-4 · Cited by 1,654
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., Labella, A., Manson, D. K., Kubin, C., Barr, R. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2012410 · Cited by 1,625
Spike mutation D614G alters SARS-CoV-2 fitness
Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., et al. (2021) · Nature · doi:10.1038/s41586-020-2895-3 · Cited by 1,558
Remdesivir for the Treatment of Covid-19 — Preliminary Report
(2020) · New England Journal of Medicine · doi:10.1056/nejmc2022236 · Cited by 1,396
Riou, J., & Althaus, C. L. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.4.2000058 · Cited by 1,297
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · PubMed Central · Cited by 1,278
Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn
Dong, L., Tian, J., He, S., Zhu, C., Wang, J., Liu, C., & Yang, J. (2020) · JAMA · doi:10.1001/jama.2020.4621 · Cited by 1,239
Identifying airborne transmission as the dominant route for the spread of COVID-19
Zhang, R., Li, Y., Zhang, A. L., Wang, Y., & Molina, M. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009637117 · Cited by 1,236
Laboratory Diagnosis of COVID-19: Current Issues and Challenges
Tang, Y.-W., Schmitz, J. E., Persing, D. H., & Stratton, C. W. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00512-20 · Cited by 1,232
Spinner, C. D., Gottlieb, R. L., Criner, G. J., Arribas López, J. R., Cattelan, A. M., Soriano Viladomiu, A., Ogbuagu, O., Malhotra, P., Mullane, K. M., Castagna, A., et al. (2020) · JAMA · doi:10.1001/jama.2020.16349 · Cited by 1,211
High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients
Llitjos, J., Leclerc, M., Chochois, C., Monsallier, J., Ramakers, M., Auvray, M., & Merouani, K. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14869 · Cited by 1,206
Institute for Safe Medication Practices
Cohen, M. R. (2002) · Encyclopedia of Clinical Pharmacy · doi:10.3109/9780824706081.079 · Cited by 1,205
Coronavirus disease 2019 (COVID-19): current status and future perspectives
Li, H., Liu, S.-M., Yu, X.-H., Tang, S.-L., & Tang, C.-K. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105951 · Cited by 1,156
Rosenberg, E. S., Dufort, E. M., Udo, T., Wilberschied, L. A., Kumar, J., Tesoriero, J., Weinberg, P., Kirkwood, J., Muse, A., DeHovitz, J., et al. (2020) · JAMA · doi:10.1001/jama.2020.8630 · Cited by 1,156
Structures and distributions of SARS-CoV-2 spike proteins on intact virions
Ke, Z., Oton, J., Qu, K., Cortese, M., Zila, V., McKeane, L., Nakane, T., Zivanov, J., Neufeldt, C. J., Cerikan, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2665-2 · Cited by 1,149
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Costela-Ruiz, V. J., Illescas-Montes, R., Puerta-Puerta, J. M., Ruiz, C., & Melguizo-Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,121
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Cavalcanti, A. B., Zampieri, F. G., Rosa, R. G., Azevedo, L. C. P., Veiga, V. C., Avezum, A., Damiani, L. P., Marcadenti, A., Kawano-Dourado, L., Lisboa, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2019014 · Cited by 1,083
Astuti, I., & Ysrafil (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.020 · Cited by 1,070
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063
Borba, M. G. S., Val, F. F. A., Sampaio, V. S., Alexandre, M. A. A., Melo, G. C., Brito, M., Mourão, M. P. G., Brito-Sousa, J. D., Baía-da-Silva, D., Guerra, M. V. F., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8857 · Cited by 1,038 · cited 1×
“as higher rates of mortality and QTc prolongation [202,203].”
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O’Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.020 · Cited by 1,006
Buitrago-Garcia, D., Egli-Gany, D., Counotte, M. J., Hossmann, S., Imeri, H., Ipekci, A. M., Salanti, G., & Low, N. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003346 · Cited by 1,000
Mair-Jenkins, J., Saavedra-Campos, M., Baillie, J. K., Cleary, P., Khaw, F.-M., Lim, W. S., Makki, S., Rooney, K. D., Convalescent Plasma Study Group, Nguyen-Van-Tam, J. S., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu396 · Cited by 983
Can we contain the COVID-19 outbreak with the same measures as for SARS?
Wilder-Smith, A., Chiew, C. J., & Lee, V. J. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30129-8 · Cited by 954
Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection
Chai, X., Hu, L., Zhang, Y., Han, W., Lu, Z., Ke, A., Zhou, J., Shi, G., Fang, N., Fan, J., et al. (2020) · doi:10.1101/2020.02.03.931766 · Cited by 952 · cited 5×
“to proliferate and destroy these organs, causing multiple organ dysfunction syndrome (MODS) [105,106].”
BackgroundInfluentialThe American Association for the Advancement of Science
HAULTAIN, A. (1889) · Nature · doi:10.1038/040556a0 · Cited by 946
Zoonotic origins of human coronaviruses
Ye, Z.-W., Yuan, S., Yuen, K.-S., Fung, S.-Y., Chan, C.-P., & Jin, D.-Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45472 · Cited by 944
Nussbaumer-Streit, B., Mayr, V., Dobrescu, A. I., Chapman, A., Persad, E., Klerings, I., Wagner, G., Siebert, U., Christof, C., Zachariah, C., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013574 · Cited by 937
Lin, L., Lu, L., Cao, W., & Li, T. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1746199 · Cited by 914
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
Millet, J. K., & Whittaker, G. R. (2015) · Virus Research · doi:10.1016/j.virusres.2014.11.021 · Cited by 902
Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020
Wei, W. E., Li, Z., Chiew, C. J., Yong, S. E., Toh, M. P., & Lee, V. J. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6914e1 · Cited by 891
Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001402 · Cited by 867
Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2
Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020) · doi:10.1101/2020.01.26.919985 · Cited by 860
Alqahtani, J. S., Oyelade, T., Aldhahir, A. M., Alghamdi, S. M., Almehmadi, M., Alqahtani, A. S., Quaderi, S., Mandal, S., & Hurst, J. R. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233147 · Cited by 858
The Writing Committee for the REMAP-CAP Investigators, Angus, D. C., Derde, L., Al-Beidh, F., Annane, D., Arabi, Y., Beane, A., van Bentum-Puijk, W., Berry, L., Bhimani, Z., et al. (2020) · JAMA · doi:10.1001/jama.2020.17022 · Cited by 855
COVID-19: Prevention and control measures in community
GÜNER, R., HASANOĞLU, İ., & AKTAŞ, F. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2004-146 · Cited by 836
COVID-19: what has been learned and to be learned about the novel coronavirus disease
Yi, Y., Lagniton, P. N. P., Ye, S., Li, E., & Xu, R.-H. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45134 · Cited by 832
Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
Lisboa Bastos, M., Tavaziva, G., Abidi, S. K., Campbell, J. R., Haraoui, L.-P., Johnston, J. C., Lan, Z., Law, S., MacLean, E., Trajman, A., et al. (2020) · BMJ · doi:10.1136/bmj.m2516 · Cited by 832
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update
Pal, M., Berhanu, G., Desalegn, C., & Kandi, V. (2020) · Cureus · doi:10.7759/cureus.7423 · Cited by 830
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Soy, M., Keser, G., Atagündüz, P., Tabak, F., Atagündüz, I., & Kayhan, S. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05190-5 · Cited by 811
COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment
Parasher, A. (2021) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138577 · Cited by 776
The crucial roles of inflammatory mediators in inflammation: A review
Abdulkhaleq, L. A., Assi, M. A., Abdullah, R., Zamri-Saad, M., Taufiq-Yap, Y. H., & Hezmee, M. N. M. (2018) · Veterinary World · doi:10.14202/vetworld.2018.627-635 · Cited by 775
Coronavirus membrane fusion mechanism offers a potential target for antiviral development
Tang, T., Bidon, M., Jaimes, J. A., Whittaker, G. R., & Daniel, S. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104792 · Cited by 761
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study
Koo, J. R., Cook, A. R., Park, M., Sun, Y., Sun, H., Lim, J. T., Tam, C., & Dickens, B. L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30162-6 · Cited by 739
Transmission potential and severity of COVID-19 in South Korea
Shim, E., Tariq, A., Choi, W., Lee, Y., & Chowell, G. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.031 · Cited by 705
Millet, J. K., & Whittaker, G. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407087111 · Cited by 698
COVID-19: Immunology and treatment options
Felsenstein, S., Herbert, J. A., McNamara, P. S., & Hedrich, C. M. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108448 · Cited by 669
Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction
Mahase, E. (2020) · BMJ · doi:10.1136/bmj.m1036 · Cited by 657
Severe COVID-19 during Pregnancy and Possible Vertical Transmission
Alzamora, M. C., Paredes, T., Caceres, D., Webb, C. M., Valdez, L. M., & La Rosa, M. (2020) · American Journal of Perinatology · doi:10.1055/s-0040-1710050 · Cited by 642
Liu, J., Zheng, X., Tong, Q., Li, W., Wang, B., Sutter, K., Trilling, M., Lu, M., Dittmer, U., & Yang, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25709 · Cited by 620
An Update on Current Therapeutic Drugs Treating COVID-19
Wu, R., Wang, L., Kuo, H.-C. D., Shannar, A., Peter, R., Chou, P. J., Li, S., Hudlikar, R., Liu, X., Liu, Z., et al. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00216-7 · Cited by 599
Beware of the second wave of COVID-19
Xu, S., & Li, Y. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30845-x · Cited by 564
Arshad, S., Kilgore, P., Chaudhry, Z. S., Jacobsen, G., Wang, D. D., Huitsing, K., Brar, I., Alangaden, G. J., Ramesh, M. S., McKinnon, J. E., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.06.099 · Cited by 546
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial
Skipper, C. P., Pastick, K. A., Engen, N. W., Bangdiwala, A. S., Abassi, M., Lofgren, S. M., Williams, D. A., Okafor, E. C., Pullen, M. F., Nicol, M. R., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-4207 · Cited by 539
The SARS coronavirus nucleocapsid protein – Forms and functions
Chang, C.-K., Hou, M.-H., Chang, C.-F., Hsiao, C.-D., & Huang, T.-H. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2013.12.009 · Cited by 529
Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis
Bustin, S. A., & Mueller, R. (2005) · Clinical Science · doi:10.1042/cs20050086 · Cited by 529
Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results
Meltzer, D. O., Best, T. J., Zhang, H., Vokes, T., Arora, V., & Solway, J. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.19722 · Cited by 510
Type 1 interferons as a potential treatment against COVID-19
Sallard, E., Lescure, F.-X., Yazdanpanah, Y., Mentre, F., & Peiffer-Smadja, N. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104791 · Cited by 509
Mackenzie, J. S., & Smith, D. W. (2020) · Microbiology Australia · doi:10.1071/ma20013 · Cited by 507
Liu, S., Xiao, G., Chen, Y., He, Y., Niu, J., Escalante, C. R., Xiong, H., Farmar, J., Debnath, A. K., Tien, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15788-7 · Cited by 505
Exploitation of glycosylation in enveloped virus pathobiology
Watanabe, Y., Bowden, T. A., Wilson, I. A., & Crispin, M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.05.012 · Cited by 482
COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation
Salathé, M., Althaus, C. L., Neher, R., Stringhini, S., Hodcroft, E., Fellay, J., Zwahlen, M., Senti, G., Battegay, M., Wilder-Smith, A., et al. (2020) · Swiss Medical Weekly · doi:10.4414/smw.2020.20225 · Cited by 481
Burke, R. M., Midgley, C. M., Dratch, A., Fenstersheib, M., Haupt, T., Holshue, M., Ghinai, I., Jarashow, M. C., Lo, J., McPherson, T. D., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6909e1 · Cited by 475
Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19
Fadel, R., Morrison, A. R., Vahia, A., Smith, Z. R., Chaudhry, Z., Bhargava, P., Miller, J., Kenney, R. M., Alangaden, G., Ramesh, M. S., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa601 · Cited by 463
Hosseiny, M., Kooraki, S., Gholamrezanezhad, A., Reddy, S., & Myers, L. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.20.22969 · Cited by 462
Cao, Y., Wei, J., Zou, L., Jiang, T., Wang, G., Chen, L., Huang, L., Meng, F., Huang, L., Wang, N., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.019 · Cited by 456
Karimi-Zarchi, M., Neamatzadeh, H., Dastgheib, S. A., Abbasi, H., Mirjalili, S. R., Behforouz, A., Ferdosian, F., & Bahrami, R. (2020) · Fetal and Pediatric Pathology · doi:10.1080/15513815.2020.1747120 · Cited by 443
Monk, P. D., Marsden, R. J., Tear, V. J., Brookes, J., Batten, T. N., Mankowski, M., Gabbay, F. J., Davies, D. E., Holgate, S. T., Ho, L.-P., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30511-7 · Cited by 438
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
Wang, N., Shang, J., Jiang, S., & Du, L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00298 · Cited by 425
Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis
Lippi, G., Wong, J., & Henry, B. M. (2020) · Polish Archives of Internal Medicine · doi:10.20452/pamw.15272 · Cited by 421
Interferon-α2b Treatment for COVID-19
Zhou, Q., Chen, V., Shannon, C. P., Wei, X.-S., Xiang, X., Wang, X., Wang, Z.-H., Tebbutt, S. J., Kollmann, T. R., & Fish, E. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01061 · Cited by 417
Duan, L., Zheng, Q., Zhang, H., Niu, Y., Lou, Y., & Wang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.576622 · Cited by 408
Zhang, Y., National Health Commission Key Laboratory for Medical Virology, N. I. F. V. D. C. A. P., Chen, C., Zhu, S., Shu, C., Wang, D., Song, J., Song, Y., Zhen, W., Feng, Z., et al. (2020) · China CDC Weekly · doi:10.46234/ccdcw2020.033 · Cited by 401
Joyner, M. J., Bruno, K. A., Klassen, S. A., Kunze, K. L., Johnson, P. W., Lesser, E. R., Wiggins, C. C., Senefeld, J. W., Klompas, A. M., Hodge, D. O., et al. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.06.028 · Cited by 398
Infants Born to Mothers With a New Coronavirus (COVID-19)
Chen, Y., Peng, H., Wang, L., Zhao, Y., Zeng, L., Gao, H., & Liu, Y. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00104 · Cited by 392
Interrupting transmission of COVID-19: lessons from containment efforts in Singapore
Lee, V. J., Chiew, C. J., & Khong, W. X. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa039 · Cited by 391
Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019‐nCoV
Zhou, T., Liu, Q., Yang, Z., Liao, J., Yang, K., Bai, W., Lu, X., & Zhang, W. (2020) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12376 · Cited by 366
Yang, Z., Liu, J., Zhou, Y., Zhao, X., Zhao, Q., & Liu, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.062 · Cited by 363
Serology testing in the COVID-19 pandemic response
Peeling, R. W., Wedderburn, C. J., Garcia, P. J., Boeras, D., Fongwen, N., Nkengasong, J., Sall, A., Tanuri, A., & Heymann, D. L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30517-x · Cited by 360
Furtado, R. H. M., Berwanger, O., Fonseca, H. A., Corrêa, T. D., Ferraz, L. R., Lapa, M. G., Zampieri, F. G., Veiga, V. C., Azevedo, L. C. P., Rosa, R. G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31862-6 · Cited by 360
Wang, X., Guo, X., Xin, Q., Pan, Y., Hu, Y., Li, J., Chu, Y., Feng, Y., & Wang, Q. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa721 · Cited by 359
Coronavirus breakthrough: dexamethasone is first drug shown to save lives
Ledford, H. (2020) · Nature · doi:10.1038/d41586-020-01824-5 · Cited by 356
The coronavirus is mutating — does it matter?
Callaway, E. (2020) · Nature · doi:10.1038/d41586-020-02544-6 · Cited by 340
Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, 2020
Sjödin, H., Wilder-Smith, A., Osman, S., Farooq, Z., & Rocklöv, J. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.13.2000280 · Cited by 339
What Other Countries Can Learn From Italy During the COVID-19 Pandemic
Boccia, S., Ricciardi, W., & Ioannidis, J. P. A. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.1447 · Cited by 335
COVID-19 Pandemic: Prevention and Protection Measures to Be Adopted at the Workplace
Cirrincione, L., Plescia, F., Ledda, C., Rapisarda, V., Martorana, D., Moldovan, R. E., Theodoridou, K., & Cannizzaro, E. (2020) · Sustainability · doi:10.3390/su12093603 · Cited by 334
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
Wang, X., Cao, R., Zhang, H., Liu, J., Xu, M., Hu, H., Li, Y., Zhao, L., Li, W., Sun, X., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-0169-8 · Cited by 329
Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States
Fauver, J. R., Petrone, M. E., Hodcroft, E. B., Shioda, K., Ehrlich, H. Y., Watts, A. G., Vogels, C. B. F., Brito, A. F., Alpert, T., Muyombwe, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.021 · Cited by 320
Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism
Park, J.-E., Li, K., Barlan, A., Fehr, A. R., Perlman, S., McCray, P. B., & Gallagher, T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608147113 · Cited by 307
Mitjà, O., Corbacho-Monné, M., Ubals, M., Tebé, C., Peñafiel, J., Tobias, A., Ballana, E., Alemany, A., Riera-Martí, N., Pérez, C. A., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1009 · Cited by 290
Explaining among-country variation in COVID-19 case fatality rate
Sorci, G., Faivre, B., & Morand, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-75848-2 · Cited by 284
IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis
Fahey, E., & Doyle, S. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01426 · Cited by 276
Second wave COVID-19 pandemics in Europe: a temporal playbook
Cacciapaglia, G., Cot, C., & Sannino, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-72611-5 · Cited by 271
COVID-19 Contact Tracing and Data Protection Can Go Together
Abeler, J., Bäcker, M., Buermeyer, U., & Zillessen, H. (2020) · JMIR mHealth and uHealth · doi:10.2196/19359 · Cited by 245
Clusters of Coronavirus Disease in Communities, Japan, January–April 2020
Furuse, Y., Sando, E., Tsuchiya, N., Miyahara, R., Yasuda, I., Ko, Y. K., Saito, M., Morimoto, K., Imamura, T., Shobugawa, Y., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2609.202272 · Cited by 240
Horby, P., Mafham, M., Linsell, L., Bell, J. L., Staplin, N., Emberson, J. R., Wiselka, M., Ustianowski, A., Elmahi, E., Prudon, B., et al. (2020) · medRxiv · doi:10.1101/2020.07.15.20151852 · Cited by 233
Resolution of coronavirus disease 2019 (COVID-19)
Habas, K., Nganwuchu, C., Shahzad, F., Gopalan, R., Haque, M., Rahman, S., Majumder, A. A., & Nasim, T. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1797487 · Cited by 231
Self-citationParker, M. J., Fraser, C., Abeler-Dörner, L., & Bonsall, D. (2020) · Journal of Medical Ethics · doi:10.1136/medethics-2020-106314 · Cited by 226
Ye, Z., Wang, Y., Colunga-Lozano, L. E., Prasad, M., Tangamornsuksan, W., Rochwerg, B., Yao, L., Motaghi, S., Couban, R. J., Ghadimi, M., et al. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.200645 · Cited by 225
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection
Ewald, H., Raatz, H., Boscacci, R., Furrer, H., Bucher, H. C., & Briel, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006150.pub2 · Cited by 224
Nicol, T., Lefeuvre, C., Serri, O., Pivert, A., Joubaud, F., Dubée, V., Kouatchet, A., Ducancelle, A., Lunel-Fabiani, F., & Le Guillou-Guillemette, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104511 · Cited by 218
Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
Sternberg, A., & Naujokat, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118056 · Cited by 217
Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection
Menachery, V. D., Dinnon, K. H., Yount, B. L., McAnarney, E. T., Gralinski, L. E., Hale, A., Graham, R. L., Scobey, T., Anthony, S. J., Wang, L., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01774-19 · Cited by 205
Corticosteroids for treating sepsis in children and adults
Annane, D., Bellissant, É., Bollaert, P. E., Briegel, J., Keh, D., Kupfer, Y. Y., Pirracchio, R., & Rochwerg, B. N. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002243.pub4 · Cited by 200
Remdesivir for the treatment of COVID-19
Ansems, K., Grundeis, F., Dahms, K., Mikolajewska, A., Thieme, V., Piechotta, V., Metzendorf, M.-I., Stegemann, M., Benstoem, C., & Fichtner, F. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014962 · Cited by 200
Petersen, A., Bressem, K., Albrecht, J., Thieß, H.-M., Vahldiek, J., Hamm, B., Makowski, M. R., Niehues, A., Niehues, S. M., & Adams, L. C. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154317 · Cited by 196
One year update on the COVID-19 pandemic: Where are we now?
Mishra, S. K., & Tripathi, T. (2021) · Acta Tropica · doi:10.1016/j.actatropica.2020.105778 · Cited by 191
Editorial: Alveolar Macrophages in Lung Inflammation and Resolution
Hu, G., & Christman, J. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02275 · Cited by 187
Martínez-Perez, O., Vouga, M., Cruz Melguizo, S., Forcen Acebal, L., Panchaud, A., Muñoz-Chápuli, M., & Baud, D. (2020) · JAMA · doi:10.1001/jama.2020.10125 · Cited by 181
Robson, B. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.103749 · Cited by 180
Why does Japan have so few cases of COVID‐19?
Iwasaki, A., & Grubaugh, N. D. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012481 · Cited by 174
Gąsecka, A., Borovac, J. A., Guerreiro, R., Giustozzi, M., Parker, W. A., Caldeira, D., & Chiva‐Blanch, G. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07084-9 · Cited by 158
Adjuvant corticosteroid therapy for critically ill patients with COVID-19
Lu, X., Chen, T., Wang, Y., Wang, J., Zhang, B., Li, Y., & Yan, F. (2020) · Critical Care · doi:10.1186/s13054-020-02964-w · Cited by 146
The Acute Respiratory Distress Syndrome: Mechanisms and Perspective Therapeutic Approaches.
Gonzales, J. N., Lucas, R., & Verin, A. D. (2015) · PubMed · Cited by 142
Whose life to save? Scarce resources allocation in the COVID-19 outbreak
Mannelli, C. (2020) · Journal of Medical Ethics · doi:10.1136/medethics-2020-106227 · Cited by 142
Wang, Q., Qiu, Y., Li, J., Zhou, Z., Liao, C.-H., & Ge, X. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00212-7 · Cited by 138
Okada, P. A., Buathong, R., Phuygun, S., Thanadachakul, T., Parnmen, S., Wongboot, W., Waicharoen, S., Wacharapluesadee, S., Uttayamakul, S., Vachiraphan, A., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.8.2000097 · Cited by 137
Severe COVID-19: A Review of Recent Progress With a Look Toward the Future
Xie, P., Ma, W., Tang, H., & Liu, D. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00189 · Cited by 133
Effectiveness of surgical masks against influenza bioaerosols
Makison Booth, C., Clayton, M., Crook, B., & Gawn, J. M. (2013) · Journal of Hospital Infection · doi:10.1016/j.jhin.2013.02.007 · Cited by 132
Early evidence of effectiveness of digital contact tracing for SARS-CoV-2 in Switzerland
Salathé, M., Althaus, C. L., Anderegg, N., Antonioli, D., Ballouz, T., Bugnion, E., Čapkun, S., Jackson, D., Kim, S.-I., Larus, J. R., et al. (2020) · Swiss Medical Weekly · doi:10.4414/smw.2020.20457 · Cited by 131
COVID-19 vaccine trials should seek worthwhile efficacy
Krause, P. R., Fleming, T. R., Longini, I. M., Restrepo, A. M. H., Peto, R., Dean, N. E., Halloran, M., Huang, Y., Fleming, T., Gilbert, P., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31821-3 · Cited by 127
FDA approves the Pfizer-BioNTech COVID-19 vaccine
Satyanarayana, M. (2021) · C&EN Global Enterprise · doi:10.47287/cen-09931-buscon1 · Cited by 127
Non‐steroidal anti‐inflammatory drugs, prostaglandins, and COVID‐19
Robb, C. T., Goepp, M., Rossi, A. G., & Yao, C. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15206 · Cited by 116
The timing of COVID-19 transmission
Ferretti, L., Ledda, A., Wymant, C., Zhao, L., Ledda, V., Abeler-Dörner, L., Kendall, M., Nurtay, A., Cheng, H.-Y., Ng, T.-C., et al. (2020) · doi:10.1101/2020.09.04.20188516 · Cited by 112
Harms of public health interventions against covid-19 must not be ignored
Bavli, I., Sutton, B. A., & Galea, S. (2020) · BMJ · doi:10.1136/bmj.m4074 · Cited by 105
Freeman, B. D., Lester, S. N., Mills, L. A., Rasheed, M. A. U., Moye, S., Abiona, O. M., Hutchinson, G. B., Morales-Betoulle, M. E., Krapinunaya, I., Gibbons, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.24.057323 · Cited by 98
Memtsoudis, S. G., Ivascu, N. S., Pryor, K. O., & Goldstein, P. A. (2020) · British Journal of Anaesthesia · doi:10.1016/j.bja.2020.04.078 · Cited by 98
Costantino, V., Heslop, D. J., & MacIntyre, C. R. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa081 · Cited by 98
Systemic inflammation as fuel for acute liver injury in COVID-19
Effenberger, M., Grander, C., Grabherr, F., Griesmacher, A., Ploner, T., Hartig, F., Bellmann‐Weiler, R., Joannidis, M., Zoller, H., Weiß, G., et al. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.08.004 · Cited by 97
Association between cytokine profiles and lung injury in COVID-19 pneumonia
Chen, L., Zhang, Z., Wei, X., Cai, Y., Yao, W.-Z., Wang, M., Huang, Q.-F., & Zhang, X. (2020) · Respiratory Research · doi:10.1186/s12931-020-01465-2 · Cited by 96
Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19
Wu, Y., Huang, X., Sun, J., Xie, T., Lei, Y., Jamal, M., Li, X., Zeng, X., Zhou, F., Qin, H., et al. (2020) · mSphere · doi:10.1128/msphere.00362-20 · Cited by 95
SARS-CoV-2 infection serology: a useful tool to overcome lockdown?
Nuccetelli, M., Pieri, M., Grelli, S., Ciotti, M., Miano, R., Andreoni, M., & Bernardini, S. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-0275-2 · Cited by 94
Testing for SARS-CoV-2 antibodies
Watson, J., Richter, A. G., & Deeks, J. J. (2020) · BMJ · doi:10.1136/bmj.m3325 · Cited by 92
Can steroids reverse the severe COVID‐19 induced “cytokine storm”?
Kolilekas, L., Loverdos, K., Giannakaki, S., Vlassi, L., Levounets, A., Ζervas, Ε., & Gaga, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26165 · Cited by 84
Yuan, M., Xu, X., Xia, D., Tao, Z., Yin, W., Tan, W., Hu, Y., & Song, C. (2020) · Shock · doi:10.1097/shk.0000000000001574 · Cited by 79
The Minimal Effect of Zinc on the Survival of Hospitalized Patients With COVID-19
Yao, J. S., Paguio, J. A., Dee, E. C., Tan, H. C., Moulick, A. N., Milazzo, C., Jurado, J., Penna, N. D., & Celi, L. A. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.06.082 · Cited by 78
Bimonte, S., Crispo, A., Amore, A., Celentano, E., Cuomo, A., & Cascella, M. (2020) · In Vivo · doi:10.21873/invivo.11949 · Cited by 71
Asymptomatic and presymptomatic transmission of SARS-CoV-2: A systematic reviewPreprint
Savvides, C. S., & Siegel, R. (2020) · medRxiv · doi:10.1101/2020.06.11.20129072 · Cited by 68
Sensitivity of different RT-qPCR solutions for SARS-CoV-2 detection
Alcoba-Flórez, J., Gil-Campesino, H., de Artola, D. G.-M., González‐Montelongo, R., Valenzuela-Fernández, A., Ciuffreda, L., & Flores, C. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.07.058 · Cited by 66
Moderna COVID vaccine becomes second to get US authorization
Ledford, H. K. (2020) · Nature · doi:10.1038/d41586-020-03593-7 · Cited by 66
Can SARS-CoV-2 Accumulate Mutations in the S-Protein to Increase Pathogenicity?
Padhi, A. K., & Tripathi, T. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00113 · Cited by 65
Early IFN type I response: Learning from microbial evasion strategies
Coccia, E. M., & Battistini, A. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.005 · Cited by 64
High‐dose, short‐term corticosteroids for ARDS caused by COVID ‐19: a case series
So, C., Ro, S., Murakami, M., Imai, R., & Jinta, T. (2020) · Respirology Case Reports · doi:10.1002/rcr2.596 · Cited by 64
Acute Kidney Injury in the 2019 Novel Coronavirus Disease
Qian, J.-Y., Wang, B., & Liu, B. (2020) · Kidney Diseases · doi:10.1159/000509086 · Cited by 63
COVID-19 and ethnicity: A novel pathophysiological role for inflammation
Vepa, A., Bae, J. P., Ahmed, F., Pareek, M., & Khunti, K. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.056 · Cited by 63
Coronavirus Disease-2019 (COVID-19) Clinical Features
Kubat, G. O., & Şahin, C. (2020) · kulak burun boğaz ve baş boyun cerrahisi dergisi · doi:10.24179/kbbbbc.2020-75703 · Cited by 61
Cited by
Ha, J. Y., & Sung, W. Y. (2022) · Medicine · doi:10.1097/md.0000000000030633 · Cited by 12
Baroni, A., Fregna, G., Lamberti, N., Manfredini, F., & Straudi, S. (2024) · European Journal of Pain · doi:10.1002/ejp.2228 · Cited by 10
Metadata
- Authors
- Rahman, S., Montero, M. T. V., Rowe, K., Kirton, R., & Kunik, F.
- Venue
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Published
- 2021-05-03
- Volume
- 14
- Issue
- 5
- Pages
- 601-621
- ISSN
- 1751-2433 (ISSN-L)
- 1751-2441
- OpenAlex
- W3135057655
- Cited by
- 289
- References
- 213
- FWCI
- 18.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.